Predictiv AI’s channel reseller secures ThermalPass orders in Quebec
KleinCity Group has closed a number of purchase orders for the ThermalPass system.
TORONTO — Predictiv AI Inc., a software and solutions provider in the artificial intelligence markets, provides an update on its channel reseller activities (KleinCity Group) in Quebec and Atlantic Canada.
KleinCity Group currently has 10 franchisees and its clients include some of the largest companies in Quebec across industries such as healthcare, mining, retail, commercial properties, hospitality and various government departments and agencies. KleinCity Group has secured orders for delivery of units to hospitals and long-term care facilities in the province of Quebec.
The Company is actively onboarding resellers with established channels throughout Canada, the U.S., and Europe. These resellers have already successfully closed a handful of purchase orders. Over the coming months, it is expected that these channel partners will accelerate unit orders and adoption of the ThermalPass system in their respective jurisdictions.
“KleinCity Group is extremely proud to represent ThermalPass in Quebec and the Maritimes. Our franchisees are offering this state-of-the-art ThermalPass system to all clients within their respective network concerned with taking preventive health and safety measures,” said Vincent Bernier, VP of Development and Public Relations of KleinCity Group. “The sales generated to date are only a small portion relative to the high volume of inbound calls and written requests we’ve been receiving about ThermalPass.”
“The early sales success from our channel resellers demonstrates that customers are willing to purchase and deploy the ThermalPass system even with vaccines for COVID-19 beginning to be rolled out around the world,” said Michael Lende, President and CEO of Predictiv AI. “Our team firmly believes that we are all now living a new normal and that AI-driven solutions and screening systems for health and wellness are here to stay.”
Predictiv AI is not making any express or implied claims that its product has the ability to eliminate, cure, or contain the COVID-19 (or SARS-2 coronavirus) at this time.